509 related articles for article (PubMed ID: 20977545)
61. Clinical presentation of childhood neuroborreliosis; neurological examination may be normal.
Broekhuijsen-van Henten DM; Braun KP; Wolfs TF
Arch Dis Child; 2010 Nov; 95(11):910-4. PubMed ID: 20584849
[TBL] [Abstract][Full Text] [Related]
62. Prospective comparison of two enzyme-linked immunosorbent spot assays for the diagnosis of Lyme neuroborreliosis.
van Gorkom T; Voet W; Sankatsing SUC; Nijhuis CDM; Ter Haak E; Kremer K; Thijsen SFT
Clin Exp Immunol; 2020 Mar; 199(3):337-356. PubMed ID: 31665540
[TBL] [Abstract][Full Text] [Related]
63. Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis.
Henningsson AJ; Gyllemark P; Lager M; Skogman BH; Tjernberg I
APMIS; 2016 Nov; 124(11):985-990. PubMed ID: 27651242
[TBL] [Abstract][Full Text] [Related]
64. Lyme neuroborreliosis in adults: A nationwide prospective cohort study.
Nordberg CL; Bodilsen J; Knudtzen FC; Storgaard M; Brandt C; Wiese L; Hansen BR; Andersen ÅB; Nielsen H; Lebech AM;
Ticks Tick Borne Dis; 2020 Jul; 11(4):101411. PubMed ID: 32178995
[TBL] [Abstract][Full Text] [Related]
65. Laboratory diagnosis of Lyme neuroborreliosis: a comparison of three CSF anti-Borrelia antibody assays.
Henningsson AJ; Christiansson M; Tjernberg I; Löfgren S; Matussek A
Eur J Clin Microbiol Infect Dis; 2014 May; 33(5):797-803. PubMed ID: 24263552
[TBL] [Abstract][Full Text] [Related]
66. Antibodies to recombinant decorin-binding proteins A and B in the cerebrospinal fluid of patients with Lyme neuroborreliosis.
Panelius J; Sillanpää H; Seppälä I; Sarvas H; Lahdenne P
Scand J Infect Dis; 2007; 39(9):775-80. PubMed ID: 17701715
[TBL] [Abstract][Full Text] [Related]
67. Characteristics and Clinical Outcome of Lyme Neuroborreliosis in a High Endemic Area, 1995-2014: A Retrospective Cohort Study in Denmark.
Knudtzen FC; Andersen NS; Jensen TG; Skarphédinsson S
Clin Infect Dis; 2017 Oct; 65(9):1489-1495. PubMed ID: 29048514
[TBL] [Abstract][Full Text] [Related]
68. Peripheral facial palsy as an initial symptom of Lyme neuroborreliosis in an Austrian endemic area.
Kindler W; Wolf H; Thier K; Oberndorfer S
Wien Klin Wochenschr; 2016 Nov; 128(21-22):837-840. PubMed ID: 25576332
[TBL] [Abstract][Full Text] [Related]
69. Evaluation of an internally controlled real-time PCR targeting the ospA gene for detection of Borrelia burgdorferi sensu lato DNA in cerebrospinal fluid.
Gooskens J; Templeton KE; Claas EC; van Dam AP
Clin Microbiol Infect; 2006 Sep; 12(9):894-900. PubMed ID: 16882295
[TBL] [Abstract][Full Text] [Related]
70. Clinical manifestations and long-term outcome of early Lyme neuroborreliosis according to the European Federation of Neurological Societies diagnostic criteria (definite versus possible) in central Europe. A retrospective cohort study.
Stupica D; Bajrović FF; Blagus R; Cerar Kišek T; Collinet-Adler S; Lah A; Levstek E; Ružić-Sabljić E
Eur J Neurol; 2021 Sep; 28(9):3155-3166. PubMed ID: 34114701
[TBL] [Abstract][Full Text] [Related]
71. Anti-inflammatory effects of dexamethasone and meloxicam on Borrelia burgdorferi-induced inflammation in neuronal cultures of dorsal root ganglia and myelinating cells of the peripheral nervous system.
Ramesh G; Meisner OC; Philipp MT
J Neuroinflammation; 2015 Dec; 12():240. PubMed ID: 26700298
[TBL] [Abstract][Full Text] [Related]
72. Occurrence of erythema migrans in children with Lyme neuroborreliosis and the association with clinical characteristics and outcome - a prospective cohort study.
Backman K; Skogman BH
BMC Pediatr; 2018 Jun; 18(1):189. PubMed ID: 29890951
[TBL] [Abstract][Full Text] [Related]
73. Retrospective Evaluation of Various Serological Assays and Multiple Parameters for Optimal Diagnosis of Lyme Neuroborreliosis in a Routine Clinical Setting.
van Gorkom T; Voet W; van Arkel GHJ; Heron M; Hoeve-Bakker BJA; Notermans DW; Thijsen SFT; Kremer K
Microbiol Spectr; 2022 Jun; 10(3):e0006122. PubMed ID: 35404103
[TBL] [Abstract][Full Text] [Related]
74. Diagnosis of Lyme neuroborreliosis with antibodies to recombinant proteins DbpA, BBK32, and OspC, and VlsE IR6 peptide.
Panelius J; Lahdenne P; Saxén H; Carlsson SA; Heikkilä T; Peltomaa M; Lauhio A; Seppälä I
J Neurol; 2003 Nov; 250(11):1318-27. PubMed ID: 14648148
[TBL] [Abstract][Full Text] [Related]
75. Antigen biochips verify and extend the scope of antibody detection in Lyme borreliosis.
Du W; Ma X; Nyman D; Povlsen K; Akguen N; Schneider EM
Diagn Microbiol Infect Dis; 2007 Dec; 59(4):355-63. PubMed ID: 17888607
[TBL] [Abstract][Full Text] [Related]
76. Clinical manifestations of Lyme neuroborreliosis in children: a review.
Bruinsma RA; Zomer TP; Skogman BH; van Hensbroek MB; Hovius JW
Eur J Pediatr; 2023 May; 182(5):1965-1976. PubMed ID: 36856886
[TBL] [Abstract][Full Text] [Related]
77. Multiple sclerosis and Lyme borreliosis.
Schmutzhard E
Wien Klin Wochenschr; 2002 Jul; 114(13-14):539-43. PubMed ID: 12422598
[TBL] [Abstract][Full Text] [Related]
78. Consequences of the Edge Effect in a Commercial Enzyme-Linked Immunosorbent Assay for the Diagnosis of Lyme Neuroborreliosis.
van Gorkom T; van Arkel GHJ; Voet W; Thijsen SFT; Kremer K
J Clin Microbiol; 2021 Jul; 59(8):e0328020. PubMed ID: 33980651
[TBL] [Abstract][Full Text] [Related]
79. C6-peptide serology as diagnostic tool in neuroborreliosis.
Tjernberg I; Schön T; Ernerudh J; Wistedt AC; Forsberg P; Eliasson I
APMIS; 2008 May; 116(5):393-9. PubMed ID: 18452429
[TBL] [Abstract][Full Text] [Related]
80. Ophthalmological findings in neuroborreliosis - a prospective study performed in western Sweden.
Škiljić D; Gustavsson M; Dotevall L; Norrsell K; Grönlund MA
Acta Ophthalmol; 2019 Feb; 97(1):44-52. PubMed ID: 30146785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
